195 related articles for article (PubMed ID: 30622514)
21. Hungry bone syndrome two weeks after starting cinacalcet: a call for caution.
Koubar SH; Qannus AA; Medawar W; Abu-Alfa AK
CEN Case Rep; 2018 May; 7(1):21-23. PubMed ID: 29124559
[TBL] [Abstract][Full Text] [Related]
22. Primary hyperparathyroidism in pregnancy treated with cinacalcet: a case report and review of the literature.
Vera L; Oddo S; Di Iorgi N; Bentivoglio G; Giusti M
J Med Case Rep; 2016 Dec; 10(1):361. PubMed ID: 27998296
[TBL] [Abstract][Full Text] [Related]
23. [Surgical therapy concept in primary hyperparathyroidism].
Rusterholz D; Müller W
Schweiz Med Wochenschr Suppl; 2000; 116():62S-65S. PubMed ID: 10780075
[TBL] [Abstract][Full Text] [Related]
24. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
Torres PU
J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
[TBL] [Abstract][Full Text] [Related]
25. Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery.
Khan A; Bilezikian J; Bone H; Gurevich A; Lakatos P; Misiorowski W; Rozhinskaya L; Trotman ML; Tóth M
Eur J Endocrinol; 2015 May; 172(5):527-35. PubMed ID: 25637076
[TBL] [Abstract][Full Text] [Related]
26. Paricalcitol and cinacalcet have disparate actions on parathyroid oxyphil cell content in patients with chronic kidney disease.
Ritter C; Miller B; Coyne DW; Gupta D; Zheng S; Brown AJ; Slatopolsky E
Kidney Int; 2017 Nov; 92(5):1217-1222. PubMed ID: 28750928
[TBL] [Abstract][Full Text] [Related]
27. Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.
Del Prete M; Marotta V; Ramundo V; Marciello F; Di Sarno A; Esposito R; Carratù AC; De Luca Di Roseto C; Di Somma C; Colao A; Faggiano A
Minerva Endocrinol; 2013 Dec; 38(4):389-94. PubMed ID: 24285106
[TBL] [Abstract][Full Text] [Related]
28. Parathyroid hemorrhage occurring after administration of cinacalcet in a patient with secondary hyperparathyroidism.
Nagasawa M; Ubara Y; Suwabe T; Yamanouchi M; Hayami N; Sumida K; Hattori Y; Tsukamoto M; Hiramatsu E; Hasegawa E; Hoshino J; Sawa N; Marui Y; Nakamura M; Tomikawa S; Takaichi K
Intern Med; 2012; 51(24):3401-4. PubMed ID: 23257528
[TBL] [Abstract][Full Text] [Related]
29. Tolerance and efficacy of a low dose of the calcimimetic agent cinacalcet in controlling moderate to severe secondary hyperparathyroidism in hemodialysis patients.
Bashir SO; Omer HA; Aamer MA; Somialy R; Morsy MD
Saudi J Kidney Dis Transpl; 2015 Nov; 26(6):1135-41. PubMed ID: 26586050
[TBL] [Abstract][Full Text] [Related]
30. Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
Block GA; Bushinsky DA; Cheng S; Cunningham J; Dehmel B; Drueke TB; Ketteler M; Kewalramani R; Martin KJ; Moe SM; Patel UD; Silver J; Sun Y; Wang H; Chertow GM
JAMA; 2017 Jan; 317(2):156-164. PubMed ID: 28097356
[TBL] [Abstract][Full Text] [Related]
31. Cinacalcet in hyperparathyroidism management after pediatric renal transplantation.
Niel O; Maisin A; Macher MA; Peuchmaur M; Deschênes G
CEN Case Rep; 2016 Nov; 5(2):141-143. PubMed ID: 28508965
[TBL] [Abstract][Full Text] [Related]
32. [The influence of side effects related to cinacalcet therapy on compliance in hemodialysis patients suffering from secondary hyperparathyroidism].
Zwiech R; Chrul S
Wiad Lek; 2012; 65(3):145-50. PubMed ID: 23289260
[TBL] [Abstract][Full Text] [Related]
33. Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride.
Sloand JA; Shelly MA
Am J Kidney Dis; 2006 Nov; 48(5):832-7. PubMed ID: 17060004
[TBL] [Abstract][Full Text] [Related]
34. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.
Block GA; Martin KJ; de Francisco AL; Turner SA; Avram MM; Suranyi MG; Hercz G; Cunningham J; Abu-Alfa AK; Messa P; Coyne DW; Locatelli F; Cohen RM; Evenepoel P; Moe SM; Fournier A; Braun J; McCary LC; Zani VJ; Olson KA; Drüeke TB; Goodman WG
N Engl J Med; 2004 Apr; 350(15):1516-25. PubMed ID: 15071126
[TBL] [Abstract][Full Text] [Related]
35. Successful Reversal of Furosemide-Induced Secondary Hyperparathyroidism With Cinacalcet.
Srivastava T; Jafri S; Truog WE; Sebestyen VanSickle J; Manimtim WM; Alon US
Pediatrics; 2017 Dec; 140(6):. PubMed ID: 29192005
[TBL] [Abstract][Full Text] [Related]
36. Cinacalcet versus standard treatment for chronic kidney disease: a systematic review and meta-analysis.
Sekercioglu N; Busse JW; Sekercioglu MF; Agarwal A; Shaikh S; Lopes LC; Mustafa RA; Guyatt GH; Thabane L
Ren Fail; 2016 Jul; 38(6):857-74. PubMed ID: 27137817
[TBL] [Abstract][Full Text] [Related]
37. [Low-dose cinacalcet reduces serum calcium in patients with primary hyperparathyroidism not eligible for surgery].
Arranz Martín A; Azcárate Villalón A; Luque Ramírez M; Santana Durán B; Marazuela Azpíroz M; Paniagua Ruiz A; Carraro R; Gómez Pan A
Endocrinol Nutr; 2011 Jan; 58(1):24-31. PubMed ID: 21277266
[TBL] [Abstract][Full Text] [Related]
38. Treatment with cinacalcet in 29 kidney transplant patients with persistent hyperparathyroidism.
López V; Toledo R; Sola E; Gutiérrez C; Sujan S; Rodríguez MA; Cabello M; Burgos D; González Molina M; Hernández D
Transplant Proc; 2009; 41(6):2394-5. PubMed ID: 19715930
[TBL] [Abstract][Full Text] [Related]
39. Remission of primary hyperparathyroidism due to spontaneous infarction of a parathyroid adenoma. Case report and review of the literature.
Kovacs KA; Gay JD
Medicine (Baltimore); 1998 Nov; 77(6):398-402. PubMed ID: 9854603
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism.
Serra AL; Schwarz AA; Wick FH; Marti HP; Wüthrich RP
Nephrol Dial Transplant; 2005 Jul; 20(7):1315-9. PubMed ID: 15941845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
